Current best practice in pulmonary rehabilitation for chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease

Volumn 6, Issue 4, 2012, Pages 221-237

  de Blasio, Francesco ^a   Polverino, Mario ^b  

^a Private Hospital   (Italy)

^b Umberto I Hospital   (Italy)

Author keywords

comorbidities; muscle dysfunction; phenotypes; pulmonary rehabilitation

Indexed keywords

C REACTIVE PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL HYPOXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; EMPHYSEMA; EVIDENCE BASED PRACTICE; EXERCISE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOMERULUS FILTRATION RATE; GOOD CLINICAL PRACTICE; HEALTH CARE UTILIZATION; HUMAN; HYPERINFLATION; KIDNEY FAILURE; MUSCLE ATROPHY; OSTEOPOROSIS; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SKELETAL MUSCLE; SURVIVAL;

BENCHMARKING; COMBINED MODALITY THERAPY; COMORBIDITY; DYSPNEA; EVIDENCE-BASED MEDICINE; EXERCISE TOLERANCE; HUMANS; LUNG; PATIENT CARE TEAM; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RECOVERY OF FUNCTION; RESPIRATORY THERAPY; TREATMENT OUTCOME;

EID: 84864763556     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465812444712     Document Type: Article

References (99)

1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111–117.
2. Agusti A.G. Noguera A. Sauleda J. Sala E. Pons J. Busquets X. (2003) Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21: 347–360.
3. Agusti A.G. Sauleda J. Miralles C. Gomez C. Togores B. Sala E. (2002) Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 485–489.
4. Annegarn J. Spruit M.A. Uszko-Lencer N.H. Vanbelle S. Savelberg H.H. Schols A.M. (2011) Objective physical activity assessment in patients with chronic organ failure: a validation study of a new single-unit activity monitor. Arch Phys Med Rehabil 92: 1852–1857.
5. Antonelli-Incalzi R. Corsonello A. Pedone C. Trojano L. Acanfora D. Spada A. (2006) Drawing impairment predicts mortality in severe COPD. Chest 130: 1687–1694.
6. Baarends E.M. Schols A.M. Slebos D.J. Mostert R. Janssen P.P. Wouters E.F. (1995) Metabolic and ventilatory response pattern to arm elevation in patients with COPD and healthy age-matched subjects. Eur Respir J 8: 1345–1351.
7. Borson S. Claypoole K. McDonald G.J. (1998) Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry 3: 115–130.
8. Bourbeau J. Julien M. Maltais F. Rouleau M. Beaupre A. Begin R. (2003) Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 163: 585–591.
9. Butcher S.J. Jones R.L. (2006) The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease. Sports Med 36: 307–325.
10. California Pulmonary Rehabilitation Collaborative Group (2004) Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J Cardiopulm Rehabil 24: 52–62.
11. Casaburi R. ZuWallack R. (2009) Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 360: 1329–1335.
12. Celli B.R. (2006) Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am Thorac Soc 3: 461–465.
13. Celli B.R. Cote C.G. Lareau S.C. Meek P.M. (2008) Predictors of Survival in COPD: more than just the FEV1. Respir Med 102(Suppl. 1): S27's35.
14. Celli B.R. Cote C.G. Marin J.M. Casanova C. Montes de O.M. Mendez R.A. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005–1012.
15. Celli B.R. Rassulo J. Make B.J. (1986) Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med 314: 1485–1490.
16. Criner G.J. Celli B.R. (1988) Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic airflow obstruction. Am Rev Respir Dis 138: 856–861.
17. Crisafulli E. Costi S. De Blasio F. Biscione G. Americi F. Penza S. (2007) Effects of a walking aid in COPD patients receiving oxygen therapy. Chest 131: 1068-1074.
18. De Benedetto F. Del P.A. Marinari S. Spacone A. (2000) In COPD patients, body weight excess can mask lean tissue depletion: a simple method of estimation. Monaldi Arch Chest Dis 55: 273–278.
19. Debigare R. Cote C.H. Maltais F. (2001) Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 164: 1712–1717.
20. Debigare R. Cote C.H. Maltais F. (2010) Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 7: 84–90.
21. De Blasio F. (2009) Pulmonary physicians and respiratory physiotherapy: the ‘other side’ of the chest. Respiration 77: 23–24.
22. Decramer M. (2008) Pulmonary rehabilitation 2007: from bench to practice and back. Clin Invest Med 31: E312–E318.
23. Di Francia M. Barbier D. Mege J.L. Orehek J. (1994) Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150: 1453–1455.
24. Dolmage T.E. Maestro L. Avendano M.A. Goldstein R.S. (1993) The ventilatory response to arm elevation of patients with chronic obstructive pulmonary disease. Chest 104: 1097–1100.
25. Donahoe M. Rogers R.M. Wilson D.O. Pennock B.E. (1989) Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 140: 385–391.
26. Du Moulin M. Taube K. Wegscheider K. Behnke M. van den Bussche H. (2009) Home-based exercise training as maintenance after outpatient pulmonary rehabilitation. Respiration 77: 139–145.
27. Eickhoff P. Valipour A. Kiss D. Schreder M. Cekici L. Geyer K. (2008) Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178: 1211–1218.
28. Epstein S.K. Celli B.R. Williams J. Tarpy S. Roa J. Shannon T. (1995) Ventilatory response to arm elevation. Its determinants and use in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: 211–216.
29. Fagevik O.M. Westerdahl E. (2009) Positive expiratory pressure in patients with chronic obstructive pulmonary disease ’ a systematic review. Respiration 77: 110–118.
30. Fix A.J. Daughton D. Kass I. Bell C.W. Golden C.J. (1985) Cognitive functioning and survival among patients with chronic obstructive pulmonary disease. Int J Neurosci 27: 13–17.
31. Foglio K. Bianchi L. Ambrosino N. (2001) Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 119: 1696–1704.
32. Franssen F.M. Wouters E.F. Baarends E.M. Akkermans M.A. Schols A.M. (2002) Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease. Med Sci Sports Exerc 34: 1570–1576.
33. Garcia Rodriguez L.A. Ruigomez A. Martin-Merino E. Johansson S. Wallander M.A. (2008) Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 134: 1223–1230.
34. Gea J. Barreiro E. (2008) [Update on the mechanisms of muscle dysfunction in COPD]. Arch Bronconeumol 44: 328–337.
35. Gigliotti F. Coli C. Bianchi R. Grazzini M. Stendardi L. Castellani C. (2005) Arm exercise and hyperinflation in patients with COPD: effect of arm training. Chest 128: 1225–1232.
36. Gonzalez C. Servera E. Marin J. (2008) Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest 133: 941–947.
37. Gosselink R. Troosters T. Decramer M. (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153: 976–980.
38. Grant I. Heaton R.K. McSweeny A.J. Adams K.M. Timms R.M. (1982) Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 142: 1470–1476.
39. Griffiths T.L. Burr M.L. Campbell I.A. Lewis-Jenkins V. Mullins J. Shiels K. (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355: 362–368.
40. Griffiths T.L. Phillips C.J. Davies S. Burr M.L. Campbell I.A. (2001) Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 56: 779–784.
41. Guell R. Casan P. Belda J. Sangenis M. Morante F. Guyatt G.H. (2000) Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 117: 976–983.
42. Guyatt G.H. Berman L.B. Townsend M. Pugsley S.O. Chambers L.W. (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42: 773–778.
43. Haas F. Salazar-Schicchi J. Axen K. (1993) Desensitization to dyspnea in chronic obstructive pulmonary disease. In: Casaburi R. PT (ed), Principles and Practice of Pulmonary Rehabilitation. W.B. Saunders: Philadelphia, pp. 241–251.
44. Haave E. Hyland M. (2008) Different short-term and longitudinal results on perceived health status for asthma and COPD patients after pulmonary rehabilitation. Patients living alone have the largest improvements in perceived quality of life. Chron Respir Dis 5: 69–73.
45. Hamilton A.L. Killian K.J. Summers E. Jones N.L. (1996) Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 110: 1255–1263.
46. Hanania N.A. Mullerova H. Locantore N.W. Vestbo J. Watkins M.L. Wouters E.F. (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183: 604–611.
47. Hargreave F.E. Parameswaran K. (2006) Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J 28: 264–267.
48. Hill N.S. (2006) Pulmonary rehabilitation. Proc Am Thorac Soc 3: 66–74.
49. Hung W.W. Wisnivesky J.P. Siu A.L. Ross J.S. (2009) Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180: 134–137.
50. Incalzi R.A. Corsonello A. Pedone C. Battaglia S. Paglino G. Bellia V. (2010) Chronic renal failure: a neglected comorbidity of COPD. Chest 137: 831–837.
51. Incalzi R.A. Corsonello A. Pedone C. Corica F. Carbonin P. Bernabei R. (2005) Construct validity of activities of daily living scale: a clue to distinguish the disabling effects of COPD and congestive heart failure. Chest 127: 830–838.
52. Iwamoto H. Yokoyama A. Kitahara Y. Ishikawa N. Haruta Y. Yamane K. (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179: 35–40.
53. Janaudis-Ferreira T. Wadell K. Sundelin G. Lindstrom B. (2006) Thigh muscle strength and endurance in patients with COPD compared with healthy controls. Respir Med 100: 1451–1457.
54. Johnston A.K. Mannino D.M. Hagan G.W. Davis K.J. Kiri V.A. (2008) Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 63: 599–605.
55. King D.A. Cordova F. Scharf S.M. (2008) Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 519–523.
56. Kortianou E.A. Nasis I.G. Spetsioti S.T. Daskalakis A.M. Vogiatzis I. (2010) Effectiveness of interval exercise training in patients with COPD. Cardiopulm Phys Ther J 21: 12–19.
57. Lacasse Y. Goldstein R. Lasserson T.J. Martin S. (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev CD003793.
58. Lareau S.C. Meek P.M. Roos P.J. (1998) Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M). Heart Lung 27: 159–168.
59. Maltais F. Hamilton A. Marciniuk D. Hernandez P. Sciurba F.C. Richter K. (2005) Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128: 1168–1178.
60. Mannino D.M. (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121: 121S–126S.
61. Mannino D.M. Thorn D. Swensen A. Holguin F. (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32: 962–969.
62. Martinez F.J. Couser J.I. Celli B.R. (1991) Respiratory response to arm elevation in patients with chronic airflow obstruction. Am Rev Respir Dis 143: 476–480.
63. Martinez-Llorens J.M. Orozco-Levi M. Masdeu M.J. Coronell C. Ramirez-Sarmiento A. Sanjuas C. (2004) [Global muscle dysfunction and exacerbation of COPD: a cohort study]. Med Clin (Barc) 122: 521–527.
64. McKenzie D.K. Butler J.E. Gandevia S.C. (2009) Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 107: 621–629.
65. Meek P.M. Lareau S.C. Anderson D. (2001) Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J 18: 474–481.
66. Mokhlesi B. Morris A.L. Huang C.F. Curcio A.J. Barrett T.A. Kamp D.W. (2001) Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 119: 1043–1048.
67. Montes de Oca M. Torres S.H. De Sanctis J. Mata A. Hernández N. Tálamo C. (2005) Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26: 390–397.
68. Mostert R. Goris A. Weling-Scheepers C. Wouters E.F. Schols A.M. (2000) Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94: 859–867.
69. Naeije R. (2005) Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 20–22.
70. Neder J.A. Sword D. Ward S.A. Mackay E. Cochrane L.M. Clark C.J. (2002) Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 57: 333–337.
71. Ng T.P. Niti M. Tan W.C. Cao Z. Ong K.C. Eng P. (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167: 60–67.
72. Nici L. Donner C. Wouters E. ZuWallack R. Ambrosino N. Bourbeau J. (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173: 1390–1413.
73. Nishimura K. Izumi T. Tsukino M. Oga T. (2002) Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121: 1434–1440.
74. Norwood R. (2006) Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 12: 113–117.
75. O–Donnell D.E. Fluge T. Gerken F. Hamilton A. Webb K. Aguilaniu B. (2004) Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23: 832–840.
76. Ottenheijm C.A. Heunks L.M. Sieck G.C. Zhan W.Z. Jansen S.M. Degens H. (2005) Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172: 200–205.
77. Patel A.R. Hurst J.R. (2011) Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 5: 647–662.
78. Pitta F. Troosters T. Spruit M.A. Probst V.S. Decramer M. Gosselink R. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 972–977.
79. Polverino F. Cosio B.G. (2009) Subphenotypes: the many faces of chronic obstructive pulmonary disease. Therapy 6: 771–773.
80. Puhan M.A. Frey M. Buchi S. Schunemann H.J. (2008) The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 6: 46.
81. Putman-Casdorph H. McCrone S. (2009) Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 38: 34–47.
82. Reid M.B. (2001) COPD as a muscle disease. Am J Respir Crit Care Med 164: 1101–1102.
83. Ries A.L. Bauldoff G.S. Carlin B.W. Casaburi R. Emery C.F. Mahler D.A. (2007) Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 131: 4S–42S.
84. Ringbaek T. Martinez G. Lange P. (2012) A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 9: 12–15.
85. Schols A.M. Broekhuizen R. Weling-Scheepers C.A. Wouters E.F. (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82: 53–59.
86. Schols A.M. Slangen J. Volovics L. Wouters E.F. (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1791–1797.
87. Serres I. Gautier V. Varray A. Prefaut C. (1998) Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 113: 900–905.
88. Sewell L. Singh S.J. Williams J.E. Collier R. Morgan M.D. (2006) How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax 61: 767–771.
89. Singh S.J. Morgan M.D. Scott S. Walters D. Hardman A.E. (1992) Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47: 1019–1024.
90. Solway S. Brooks D. Lau L. Goldstein R. (2002) The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest 122: 56–65.
91. Steele B.G. Holt L. Belza B. Ferris S. Lakshminaryan S. Buchner D.M. (2000) Quantitating physical activity in COPD using a triaxial accelerometer. Chest 117: 1359–1367.
92. Tangri S. Woolf C.R. (1973) The breathing pattern in chronic obstructive lung disease during the performance of some common daily activities. Chest 63: 126–127.
93. Troosters T. Casaburi R. Gosselink R. Decramer M. (2005) Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172: 19–38.
94. Vanfleteren L.E. Franssen F.M. Uszko-Lencer N.H. Spruit M.A. Celis M. Gorgels A.P. (2011) Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am J Cardiol 108: 1669–1674.
95. Vilaro J. Ramirez-Sarmiento A. Martinez-Llorens J.M. Mendoza T. Alvarez M. Sanchez-Cayado N. (2010) Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 104: 1896–1902.
96. Votto J. Bowen J. Scalise P. Wollschlager C. ZuWallack R. (1996) Short-stay comprehensive inpatient pulmonary rehabilitation for advanced chronic obstructive pulmonary disease. Arch Phys Med Rehabil 77: 1115–1118.
97. Watz H. Waschki B. Meyer T. Kretschmar G. Kirsten A. Claussen M. (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138: 32–38.
98. ZuWallack R. Crouch R. ed. (2004a) Guidelines for Pulmonary Rehabilitation Programs, 3rd edn. Human Kinetics edn. Champaign, IL.
99. ZuWallack R. Lareau S. Meek P. (2004b) The effect of pulmonary rehabilitation on dyspnea. In: Mahler D. (ed), Lung Biology in Health and Disease: Dyspnea. New York: Marcel Decker.